neostigmine has been researched along with Metabolic Diseases in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
MARTIN, GJ | 1 |
Bräutigam, HH | 1 |
Netter, KJ | 1 |
Rietbrock, N | 1 |
2 other studies available for neostigmine and Metabolic Diseases
Article | Year |
---|---|
The action of prostigmine in the nutritional muscular dystrophy of vitamin E deficiency.
Topics: Humans; Metabolic Diseases; Minerals; Muscular Dystrophies; Neostigmine; Vitamin E; Vitamin E Defici | 1946 |
[Postoperative apnea after suxamethonium].
Topics: Adult; Apnea; Bis-Trimethylammonium Compounds; Blood Transfusion; Cholinesterases; Female; Humans; M | 1966 |